Omnicell Limited engages Evergreen PR to help drive customer uptake of medicine management solutions
Omnicell Limited, a subsidiary of Omnicell, Inc. (NASDAQ:OMCL) (“Omnicell” or the “Company”), a leading healthcare technology provider focused on empowering autonomous medication management, has engaged specialist healthcare PR agency Evergreen PR to assist in accelerating the adoption of its medication management solutions across UK hospitals.
Omnicell's technology is designed to deliver end-to-end real-time visibility of medication and supplies across all point of care and central pharmacy locations, intended to enable healthcare providers to make more informed, data-driven decisions that strengthen compliance, improve operational efficiency and help address challenges such as medicine shortages, workforce pressures and supply chain disruption.
Omnicell Limited, which has operations headquartered in Warrington, is a trusted partner to NHS Trusts, hospitals and community pharmacies across the UK, focused on helping healthcare organisations drive safer, more efficient and more connected medication management.
Evergreen PR will deliver campaigns that establish Omnicell's market leadership in interoperability, native integration, automation and intelligence, showcasing the impact its technology is already having across NHS Trusts and hospitals throughout the UK.
The agency was selected following a competitive pitch process. Although initially engaged for a single project, the scope of the collaboration has already expanded as the relationship develops.
Kerry Barnard, Senior Marketing Manager, UK & Ireland, said: "We're delighted to be working with Evergreen PR. In a short space of time, we've already been impressed by their insight-driven approach, original ideas and the flexibility they bring to meeting our objectives."
Leigh Greenwood, Managing Director of Evergreen PR, said: "We're genuinely excited about this relationship. We believe Omnicell's technology has the potential to transform medication management across UK hospitals, and we're looking forward to helping them tell that story."